Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Makris, A
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients, CLIN CANC R, 6(2), 2000, pp. 616-621
Authors:
Gregory, RK
Hill, ME
Moore, J
A'Hern, RP
Johnston, SRD
Blake, P
Shephard, J
Barton, D
Gore, ME
Citation: Rk. Gregory et al., Combining platinum, paclitaxel and anthracycline in patients with advancedgynaecological malignancy, EUR J CANC, 36(4), 2000, pp. 503-507
Authors:
Gregory, RK
Johnston, SRD
Smith, IE
Miles, D
Citation: Rk. Gregory et al., UFT/leucovorin plus bolus epirubicin and cyclophosphamide in advanced/metastatic breast cancer, ONCOLOGY-NY, 14(10), 2000, pp. 47-49
Authors:
Gregory, RK
Powles, TJ
Salter, J
Chang, JC
Ashley, S
Dowsett, M
Citation: Rk. Gregory et al., Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy, BREAST CANC, 59(2), 2000, pp. 171-175
Authors:
Gregory, RK
Cunningham, D
Fisher, TA
Rhys-Evans, P
Middleton, GW
Bishop, L
Wotherspoon, A
Trott, PA
Nash, AG
Citation: Rk. Gregory et al., Investigating lymphadenopathy - report on the first 12 months of the lymphnode diagnostic clinic at the Royal Marsden Hospital, POSTG MED J, 76(899), 2000, pp. 566-568
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashey, SE
Clark, GM
Makris, A
Assersohn, L
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer, J CL ONCOL, 17(10), 1999, pp. 3058-3063
Authors:
Gregory, RK
Powles, RL
Treleaven, JG
Smith, ML
Mortimer, PS
Wotherspoon, A
Riley, U
Citation: Rk. Gregory et al., Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia, BONE MAR TR, 23(1), 1999, pp. 103-104